|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.00 ARS | +2.53% |
|
-1.22% | -32.64% |
| Market Cap | 6.9B 4.62M 4.05M 3.73M 3.46M 6.56M 439M 6.67M 44.71M 17.39M 217M 17.36M 16.98M 749M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.64B 5.12M 4.48M 4.13M 3.83M 7.26M 486M 7.38M 49.49M 19.25M 240M 19.21M 18.8M 829M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.53% | ||
| 1 week | -1.22% | ||
| Current month | -0.61% | ||
| 1 month | +0.31% | ||
| 3 months | -14.96% | ||
| 6 months | -26.70% | ||
| Current year | -32.64% |
| 1 week | 155 | 165.5 | |
| 1 month | 155 | 171.5 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 21 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4.2 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.53% | -1.22% | +15.10% | +636.36% | 4.63M | ||
| +1.41% | +6.30% | -51.36% | -54.30% | 31.62B | ||
| -1.49% | +0.16% | +70.35% | +145.52% | 12.55B | ||
| -4.51% | +1.26% | -16.75% | +0.25% | 3.82B | ||
| +0.46% | -1.80% | -1.66% | +30.60% | 3.11B | ||
| -0.86% | +6.58% | +56.51% | +32.81% | 2.05B | ||
| -0.17% | +3.25% | -27.80% | +18.24% | 1.66B | ||
| -2.53% | +6.02% | +11.34% | +131.99% | 1.38B | ||
| -1.63% | +5.85% | -20.23% | -9.49% | 1.07B | ||
| +1.26% | +2.26% | -3.07% | -17.33% | 950M | ||
| Average | -0.54% | +1.54% | +3.24% | +91.46% | 5.82B | |
| Weighted average by Cap. | +0.00% | +1.97% | -12.87% | +7.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.55M 4.85M 4.47M 4.15M 7.87M 526M 8M 53.63M 20.85M 260M 20.82M 20.37M 898M | 6.4B 4.29M 3.76M 3.46M 3.21M 6.09M 407M 6.19M 41.5M 16.14M 201M 16.11M 15.76M 695M |
| Net income | -1.42B -950K -831K -766K -710K -1.35M -90.15M -1.37M -9.19M -3.57M -44.49M -3.57M -3.49M -154M | -4.6B -3.08M -2.7M -2.48M -2.3M -4.37M -292M -4.44M -29.8M -11.59M -144M -11.57M -11.32M -499M |
| Net Debt | 863M 578K 506K 467K 432K 821K 54.9M 834K 5.59M 2.18M 27.09M 2.17M 2.12M 93.65M | 738M 494K 433K 399K 370K 702K 46.92M 713K 4.78M 1.86M 23.16M 1.86M 1.82M 80.04M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-06 | ARS 162.00 | +2.53% | 14,507 |
| 26-07-03 | ARS 158.00 | -3.07% | 3,769 |
| 26-07-02 | ARS 163.00 | 0.00% | 9,583 |
| 26-07-01 | ARS 163.00 | 0.00% | 11,988 |
| 26-06-30 | ARS 163.00 | -0.61% | 17,133 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















